Literature DB >> 9479564

Immune recognition of influenza hemagglutinin as a viral and a neo-self-antigen.

A J Caton1, D M Cerasoli, F F Shih.   

Abstract

To analyze mechanisms governing tolerance and autoimmunity to self-antigens, we have generated lineages of transgenic mice that express the influenza virus PR8 hemagglutinin (HA) as a neo-self-antigen. By comparing the HA-specific T and B cell responses that can be induced in HA Tg mice with those that are induced in non-Tg (BALB/c) mice, the specificity and genetic basis with which tolerance is induced to the HA has been examined. This article summarizes studies using lineages of HA Tg mice that express different forms and amounts of the HA under the control of the SV40 promoter/enhancer. Our studies have revealed that specific subsets of HA-specific T and B cells are negatively selected from the primary repertoires of HA Tg mice. However, substantial populations of HA-specific T and B cells evade negative selection and can be activated by virus immunization. Understanding the capacity of these autoreactive lymphocytes to differentiate and participate in antigen-specific immune responses will provide important insights into mechanisms by which autoimmunity might be induced by viruses bearing structural similarities with self-antigens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9479564     DOI: 10.1007/BF02786427

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  58 in total

1.  A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin.

Authors:  J Kavaler; A J Caton; L M Staudt; D Schwartz; W Gerhard
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

Review 2.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 3.  T and B memory cells.

Authors:  J Sprent
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 4.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  Limited capacity for tolerization of CD4+ T cells specific for a pancreatic beta cell neo-antigen.

Authors:  I Förster; R Hirose; J M Arbeit; B E Clausen; D Hanahan
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

8.  Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection.

Authors:  L J Berg; B Fazekas de St Groth; A M Pullen; M M Davis
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

9.  T cell unresponsiveness correlates with quantitative TCR levels in a transgenic model.

Authors:  R J Homer; C Mamalaki; D Kioussis; R A Flavell
Journal:  Int Immunol       Date:  1993-12       Impact factor: 4.823

10.  Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin.

Authors:  P A Scherle; W Gerhard
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  2 in total

1.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

2.  Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen.

Authors:  Gwendalyn D King; A K M Ghulam Muhammad; Daniel Larocque; Kyle R Kelson; Weidong Xiong; Chunyan Liu; Nicholas S R Sanderson; Kurt M Kroeger; Maria G Castro; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.